Atlas Trials

BRAF Gene Mutation

17 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch BRAF Gene Mutation

RecordFirmDate
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma (NCT04903119)Rina Plattner2022-06-01
Study of Ulixertinib for Patients With Advanced Malignancies Harboring MEK or Atypical BRAF Alterations (NCT04488003)BioMed Valley Discoveries, Inc2021-01-07
Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer (NCT04238624)Memorial Sloan Kettering Cancer Center2020-01-20
Neoadjuvant Use of Talimogene Laherparepvec and BRAF/MEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma (NCT03972046)TriHealth Inc.2019-06-24
Continued Access to RXDX-105 (NCT03784378)Memorial Sloan Kettering Cancer Center2018-12-14
OPTImal PALliative Anti-epidermal Growth Factor Receptor Treatment in Metastatic Colorectal Cancer - (NCT03750175)Karen-Lise Garm Spindler2018-06-01
Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma (NCT02367859)Stanford University2017-07-17
Recombinant EphB4-HSA Fusion Protein and Pembrolizumab, MK-3475 (NCT03049618)University of Southern California2017-03-10
Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction (NCT01907802)National Cancer Institute (NCI)2013-08-23
French National Observatory of the Patients With Non-small Cell Lung (NSCLC) and Molecular Testings (NCT01700582)Intergroupe Francophone de Cancerologie Thoracique2012-04-01

Track BRAF Gene Mutation automatically

Every clearance here is in the API, with alerts when new ones post.